Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UDCA in Rheumatoid Arthritis
NCT05973370Phase 2Completed
- Sponsor
- Tanta University
- Start
- May 2023
- Primary completion
- Nov 2023
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of ursodeoxycholic acid in rheumatoid arthritis (RA), sponsored by Tanta University. Started May 2023; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05973370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05973370.